Skip to ContentSkip to MenuSkip to Footer
MULTIPLE MYELOMA RECRUITMENT

Multiple Myeloma Patient Recruitment Services

Accelerate your multiple myeloma clinical trials with TheraNovex's specialized recruitment platform. Expert targeting for newly diagnosed, relapsed/refractory MM across all treatment lines.

Proven Multiple Myeloma Patient Recruitment Results

Our specialized multiple myeloma recruitment platform delivers faster enrollment across all disease stages and treatment settings.

2,100+
Multiple Myeloma Patients Successfully Recruited
29+
Completed Multiple Myeloma Studies
47%
Faster Enrollment Than Industry Average
95%
Patient Retention Rate in MM Trials

Comprehensive Multiple Myeloma Patient Recruitment

Expert recruitment across all multiple myeloma stages and treatment lines for accelerated clinical trial enrollment.

Newly Diagnosed Multiple Myeloma

First-line treatment recruitment for transplant-eligible and ineligible patients

850+ patients recruited

Relapsed/Refractory Multiple Myeloma

Advanced disease recruitment for novel agents, CAR-T, and combination therapies

1,200+ patients recruited

High-Risk Multiple Myeloma

Cytogenetically high-risk MM recruitment for intensive treatment and maintenance studies

420+ patients recruited

Smoldering Multiple Myeloma

Pre-malignant condition recruitment for early intervention and prevention trials

280+ patients recruited

Plasma Cell Leukemia

Aggressive plasma cell disorder recruitment for intensive treatment studies

95+ patients recruited

CAR-T Eligible Multiple Myeloma

Specialized recruitment for CAR-T cell therapy and cellular immunotherapy trials

320+ patients recruited

Advanced Multiple Myeloma Recruitment Strategies

Multi-channel approach combining digital outreach, hematology networks, and patient advocacy partnerships.

Digital Patient Outreach

Targeted campaigns reaching multiple myeloma patients through social media, search marketing, and patient portals

Hematology-Oncology Networks

Direct relationships with myeloma specialists, hematologists, and transplant centers

Patient Advocacy Collaboration

Partnerships with myeloma foundations, support groups, and blood cancer organizations

Cytogenetic Risk Assessment

FISH testing, cytogenetics, and risk stratification for precision recruitment

Multiple Myeloma Recruitment Process

1
Patient identification through multiple channels
2
Myeloma staging and risk stratification
3
Cytogenetic and molecular testing coordination
4
Treatment history and transplant eligibility assessment
5
Site matching based on myeloma specialization
6
Enrollment support and retention management

Ready to Accelerate Your Multiple Myeloma Study Enrollment?

Partner with TheraNovex for expert multiple myeloma patient recruitment. Our specialized platform delivers faster enrollment across all MM populations.